T. ROWE PRICE INVESTMENT MANAGEMENT, INC. Ultragenyx Pharmaceutical Inc. Transaction History

T. ROWE PRICE INVESTMENT MANAGEMENT, INC. portfolio value:

$107.97M
portfolio value

Ultragenyx Pharmaceutical Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 2.60M shares 107.97M $41.41 2.60M